Patent - Abbreviated New Drug Application Cases filed in the Third Circuit Courts
Cases 71 - 76 of 76
Onyx Therapeutics, Inc. v. Apotex Inc. et al
as 1:2017cv01202
Plaintiff: Onyx Therapeutics, Inc.
Defendant: Apotex Inc. and Apotex Corp.
Cause Of Action: 35 U.S.C. § 271
Teva Pharmaceuticals International GmbH et al v. Apotex Inc. et al
as 1:2017cv01164
Plaintiff: Teva Pharmaceuticals International GmbH , Cephalon, Inc. and Eagle Pharmaceuticals, Inc.
Defendant: Apotex Inc. and Apotex Corp.
Cause Of Action: 35 U.S.C. § 271
MERCK SHARP & DOHME CORP. v. APOTEX INC. et al
as 3:2017cv05399
Plaintiff: MERCK SHARP & DOHME CORP.
Defendant: APOTEX INC. and APOTEX CORP.
Cause Of Action: 15 U.S.C. § 1126
Mitsubishi Tanabe Pharma Corporation et al v. Apotex Inc. et al
as 1:2017cv00990
Plaintiff: Mitsubishi Tanabe Pharma Corporation , Janssen Pharmaceuticals Inc. , Janssen Pharmaceutica, N.V. and others
Defendant: Apotex Inc. and Apotex Corp.
Cause Of Action: 35 U.S.C. § 271
MITSUBISHI TANABE PHARMA CORP. et al v. APOTEX, INC., et al
as 3:2017cv05278
Plaintiff: MITSUBISHI TANABE PHARMA CORPORATION , JANSSEN PHARMACEUTICALS, INC. , JANSSEN PHARMACEUTICA NV and others
Defendant: APOTEX, INC. and APOTEX CORP.
Cause Of Action: 15 U.S.C. § 1126
AstraZeneca LP et al. v. Apotex Inc., et al.
as 1:2017cv00714
Plaintiff: AstraZeneca LP , Astrazeneca AB , AstraZeneca UK Limited and others
Defendant: Apotex Inc. and Apotex Corp.
Cause Of Action: 35 U.S.C. § 145

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?